Vincent de Caprio
Director/Board Member at New Jersey Institute of Technology
Profile
Vincent de Caprio was President and Chief Executive Officer of Vyteris Holdings, Inc. He joined Vyteris Holdings, Inc. in 2000.
He is a Fellow of the American Institute of Medical and Biological Engineering.
He is a Trustee of New Jersey Institute of Technology.
He received a BSEE degree from the Newark College of Engineering in 1972, an MS degree in 1975 from Polytechnic University and a PhD in 1977 from Polytechnic University.
Vincent de Caprio active positions
| Companies | Position | Start |
|---|---|---|
| New Jersey Institute of Technology | Director/Board Member | - |
Former positions of Vincent de Caprio
| Companies | Position | End |
|---|---|---|
Vyteris, Inc.
 Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | President | 2005-12-30 |
| Treasure Mountain Holdings, Inc. | President | 2005-05-16 |
Training of Vincent de Caprio
| New Jersey Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
| Treasure Mountain Holdings, Inc. | Producer Manufacturing |
Vyteris, Inc.
Vyteris, Inc. Pharmaceuticals: MajorHealth Technology Vyteris, Inc. develops, manufactures and commercializes pharmaceutical products. It is engaged in the process of developing first active drug delivery patch to receive marketing clearance from the U.S. Food and Drug Administration. The drug delivery patch technology allows precise dosing, giving physicians and patients control in the rate, dosage and pattern of drug delivery that may result in considerable therapeutic, economical, and lifestyle advantages over existing methods of drug administration. The company was founded on July 19, 2000 and is headquartered in Fair Lawn, NJ. | Health Technology |
| Polytechnic University | Consumer Services |
- Stock Market
- Insiders
- Vincent de Caprio
